<?xml version="1.0" encoding="UTF-8"?>
<p class="p">This systematic review suggests that EOs and their major compounds have a potential for the treatment of inflammatory diseases especially in chronic inflammatory conditions. The main action targets presented in this review for the therapy of chronic inflammations were the reduction in reactive oxygen and nitrogen species and the reduction in NF-
 <italic class="italic">Îº</italic>B reducing the expression of proinflammatory cytokines.
</p>
